Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #336152 on Anavex Life Sciences Corp (AVXL)
BIOChecker4
11/16/21 4:12 PM
#336163 RE: georgejjl #336152
nidan7500
11/16/21 4:46 PM
#336167 RE: georgejjl #336152
Catalysts to Drive Value The company has multiple clinical milestones > Top-line data AVATAR: Potentially pivotal Phase 2/3 adult RTT clinical trial – expected 2H 2021 > Top-line data Phase 1 ANAVEX®3-71 clinical trial – expected 2H 2021 >Top-line data EXCELLENCE: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected 1H 2022 >Top-line data ANAVEX®2-73-AD-004: Potentially pivotal Phase 2b/3 AD clinical trial – expected 2H 2022 >Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2021 >Pipeline expansion opportunities for ANAVEX®2-73 >Initiation of potentially pivotal Phase 2/3 Fragile X clinical trial – expected 2021 >Initiation of potentially pivotal Phase 2/3 clinical trial for the treatment of a new, rare disease indication – expected 2021
blue finch
11/16/21 4:51 PM
#336168 RE: georgejjl #336152
kund
11/16/21 5:57 PM
#336176 RE: georgejjl #336152